推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733，021-33632861

chinasupport@letpub.com

登录 注册 新注册优惠

… Early Mortality in Unrelated Donor (UD) Cord Blood (CB) Stem Cell Transplantation (SCT) Using a Preparative Regimen of Thiotepa, Fludarabine, Melphalan and …

R Nath, R Glen, W William, C Jan… - Biology of Blood and …, 2011 - bbmt.org
... Successful Engraftment and Reduced Early Mortality in Unrelated Donor (UD) Cord Blood (CB)
Stem Cell Transplantation (SCT) Using a Preparative Regimen of Thiotepa, Fludarabine,
Melphalan and Rabbit Anti-Thymocyte Globulin (TFM/r-ATG) in Older Adults With a Single ...
Cached - All 2 versions

A comprehensive understanding of thioTEPA metabolism in the mouse using UPLC-ESI-QTOFMS-based metabolomics

F Li, AD Patterson, CC Hofer, KW Krausz… - Biochemical …, 2011 - Elsevier
ThioTEPA, an alkylating agent with anti-tumor activity, has been used as an effective anticancer
drug since the 1950s. However, a complete understanding of how its alkylating activity relates
to clinical efficacy has not been achieved, the total urinary excretion of thioTEPA and its ...
Cited by 1 - Related articles - All 2 versions

Bumeltt (Busulphan, Melphalan, and Thiotepa) as a Preparative Regimen Prior to Autologous Stem Cell Transplantation in Patients With Relapsed/Refractory …

S Ganguly, V Jain, CL Divine, O Ajitawi… - Biology of Blood and …, 2011 - bbmt.org
... Bumeltt (Busulphan, Melphalan, and Thiotepa) as a Preparative Regimen Prior to Autologous
Stem Cell Transplantation in Patients With Relapsed/Refractory Hodgkin'S Disease Does Not
Offer Any Advantage Over More Standard Regimens Like Beam or BEAC. S. Ganguly: ...
Cached - All 2 versions

DNA methyltransferase inhibitor CDA-2 synergizes with high-dose thiotepa and paclitaxel in killing breast cancer stem cells.

Z Lu, J Jia, L Di, G Song, Y Yuan… - … in bioscience (Elite …, 2011 - ncbi.nlm.nih.gov
It has been suggested that breast cancer stem cells (CSCs), which characterized by
CD44+CD24-/low, may result in treatment failure in patients with breast cancer. It is possible
therefore that that inhibiting such subpopulation might subsequently improve clinical ...

Randomized clinical case-control trial for the comparison of docetaxel plus thiotepa versus docetaxel plus capecitabine in patients with metastatic breast cancer.

J Yu, LJ DI, GH Song, L Che, HF Jiang… - Beijing da xue xue …, 2011 - ncbi.nlm.nih.gov
OBJECTIVE: To evaluate the efficacy and safety of docetaxel plus thiotepa(TXT/TSPA) and docetaxel
plus capecitabine(TXT/CAPE) in patients with metastatic breast cancer. METHODS: The patients
were randomized to give intravenous TXT 35 mg/m2 on days 1 and 8 plus intravenous ...

联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

© 2010-2024 中国: LetPub上海分公司    网站备案号：沪ICP备10217908号-1    沪公网安备号：31010402006960

增值电信业务经营许可证：沪B2-20211595

礼翰商务信息咨询（上海）有限公司      办公地址：上海市徐汇区漕溪北路88号圣爱大厦1803室

United States: Tel: 1-781-202-9968 Address: 400 5th Ave, Suite 530, Waltham, Massachusetts 02451